Trial intelligence / Profile preview

Clotrimazole Vaginal Tablets for Vulvovaginal Candidiasis

CTR20255097Phase 3Active

Sponsor
Zhongyan Pharma
Start
Mar 2026
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of clotrimazole in vulvovaginal candidiasis (VVC), sponsored by Zhongyan Pharma. Started Mar 2026; status: active.

02

Drugs

clotrimazole
03

Conditions

vulvovaginal candidiasis (VVC)

Beyond the preview

Go deeper on CTR20255097.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20255097.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call